Share of Cost, Researchers find potential target for drug to treat allergic asthma

Tuesday, Jul. 29th 2014 8:00 AM

An enzyme that helps maintain immune system function by “throwing away” a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests.The finding suggests that this enzyme, called Cbl-b, could be a target for drugs used to treat allergic asthma and other autoimmune disorders.

Posted on Tuesday, Jul. 29th 2014 8:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.